...
首页> 外文期刊>Journal of Surgical Oncology >Impact of lympho‐vascular space invasion on tumor characteristics and survival outcome of women with low‐grade serous ovarian carcinoma
【24h】

Impact of lympho‐vascular space invasion on tumor characteristics and survival outcome of women with low‐grade serous ovarian carcinoma

机译:淋巴血管空间侵袭对低级浆液癌患者肿瘤特征及生存的影响

获取原文
获取原文并翻译 | 示例

摘要

Background and Objectives To examine association of lympho‐vascular space invasion (LVSI) with clinico‐pathological factors and to evaluate survival of women with low‐grade serous ovarian carcinoma containing areas of LVSI. Methods This is a multicenter retrospective study examining consecutive cases of surgically treated stage I‐IV low‐grade serous ovarian carcinoma ( n ?=?178). Archived histopathology slides for the ovarian tumors were reviewed, and LVSI was scored as present or absent. LVSI status was correlated to clinico‐pathological findings and survival outcome. Results LVSI was seen in 79 cases (44.4%, 95% confidence interval [CI] 37.1‐51.7). LVSI was associated with increased risk of omental metastasis (87.0% vs 64.9%, odds ratio [OR] 3.62, P ?=?0.001), high pelvic lymph node ratio (median 12.9% vs 0%, P ?=?0.012), and malignant ascites (49.3% vs 32.6%, OR 2.01, P ?=?0.035). On multivariable analysis, controlling for age, stage, and cytoreductive status, presence of LVSI in the ovarian tumor remained an independent predictor for decreased progression‐free survival (5‐year rates 21.0% vs 35.7%, adjusted‐hazard ratio 1.57, 95%CI 1.06‐2.34, P ?=?0.026). LVSI was significantly associated with increased risk of recurrence in lymph nodes (OR 2.62, 95%CI 1.08‐6.35, P ?=?0.047). Conclusion LVSI in the ovarian tumor is associated with adverse clinico‐pathological characteristics and decreased progression‐free survival in women with low‐grade serous ovarian carcinoma.
机译:背景与目的研究淋巴血管间隙侵犯(LVSI)与临床病理因素的关系,并评估含有LVSI区域的低度浆液性卵巢癌患者的生存率。方法:这是一项多中心回顾性研究,检查了连续例手术治疗的I-IV期低级别浆液性卵巢癌(n=178)。对卵巢肿瘤的存档组织病理切片进行回顾,LVSI评分为存在或不存在。LVSI状态与临床病理结果和生存结果相关。结果79例患者出现LVSI(44.4%,95%可信区间[CI]37.1-51.7)。LVSI与大网膜转移风险增加(87.0%对64.9%,优势比[OR]3.62,P=0.001)、盆腔淋巴结高比率(中位数12.9%对0%,P=0.012)和恶性腹水(49.3%对32.6%,或2.01,P=0.035)相关。在多变量分析中,控制年龄、分期和细胞减少状态,卵巢肿瘤中LVSI的存在仍然是无进展生存率下降的独立预测因素(5年生存率21.0%对35.7%,调整后的风险比1.57,95%可信区间1.06-2.34,P=0.026)。LVSI与淋巴结复发风险增加显著相关(OR 2.62,95%可信区间1.08-6.35,P=0.047)。结论卵巢肿瘤中的LVSI与低度浆液性卵巢癌患者的不良临床病理特征和无进展生存率降低有关。

著录项

  • 来源
    《Journal of Surgical Oncology 》 |2018年第2期| 共9页
  • 作者单位

    Division of Gynecologic Oncology Department of Obstetrics and GynecologyUniversity of Southern;

    Ovarian Cancer Action Research Center Department of Surgery and CancerImperial College;

    Division of Gynecologic Oncology Department of Obstetrics and GynecologyUniversity of Colorado;

    Division of Gynecologic Oncology Department of Obstetrics and GynecologyMoffitt Cancer Center;

    Division of Gynecologic Oncology Department of Obstetrics and GynecologyAlbert Einstein College of;

    Department of PathologyWayne State UniversityDetroit Michigan;

    Department of PathologyUniversity of Colorado Anschutz Medical CampusAurora Colorado;

    Department of Pathology Albert Einstein College of MedicineMontefiore Medical CenterNew York New;

    Ovarian Cancer Action Research Center Department of Surgery and CancerImperial College;

    Ovarian Cancer Action Research Center Department of Surgery and CancerImperial College;

    Ovarian Cancer Action Research Center Department of Surgery and CancerImperial College;

    Division of Gynecologic Oncology Department of Obstetrics and GynecologyOregon Health &

    Science;

    Department of PathologyUniversity of Colorado Anschutz Medical CampusAurora Colorado;

    Division of Gynecologic Oncology Department of Obstetrics and GynecologyUniversity of Southern;

    Division of Gynecologic Oncology Department of Obstetrics and GynecologyUniversity of Southern;

    Department of Gynecologic Oncology &

    Reproductive MedicineThe University of Texas MD Anderson;

    Department of Pathology Albert Einstein College of MedicineMontefiore Medical CenterNew York New;

    Division of Gynecologic Oncology Department of Obstetrics and GynecologyOregon Health &

    Science;

    Department of PathologyUniversity of Southern CaliforniaLos Angeles California;

    Division of Gynecologic Oncology Department of Obstetrics and GynecologyAlbert Einstein College of;

    Department of Pathology Albert Einstein College of MedicineMontefiore Medical CenterNew York New;

    Clinical Discovery UnitEarly Clinical DevelopmentAstraZeneca Cambridge UK;

    Division of Gynecologic Oncology Department of Obstetrics and GynecologyUniversity of Colorado;

    Division of Gynecologic Oncology Department of Obstetrics and GynecologyUniversity of Southern;

    Ovarian Cancer Action Research Center Department of Surgery and CancerImperial College;

    Ovarian Cancer Action Research Center Department of Surgery and CancerImperial College;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学 ;
  • 关键词

    low‐grade serous; lymphovascular space invasion; ovarian cancer;

    机译:低度浆液性;淋巴血管间隙侵犯;卵巢癌;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号